samedan logo
 
 
spacer
home > epc > Winter 2015
PUBLICATIONS

European Pharmaceutical Contractor

epc
Winter 2015

   
Text
PDF
bullet
Marketplace & Business
CRO Growth

Deal Me In


Contract research continues to thrive as CROs strengthen their R&D services and sponsors tighten their budgets. Growth is surging this year and predicted to at least the end of the decade, driven by the big players and market consolidation. EPC has more.
 
view
download pdf
bullet
Legal & Regulatory
Patent Protection

Optional Extras


It is uncertain times for patent portfolios in Europe, with pharma companies large and small working out whether to opt in or out of the Unifi ed Patent Court system, coming in 2017. The risks, rewards and crucially costs of the new regime must all be weighed up, says Paul Harris at Pillsbury Law.
 
view
download pdf
bullet
Science & Innovation
Business Models

Eco Friendly

A new ecosystem model is rapidly evolving in pharma and life sciences. Heather Fraser at IBM explains how it will require a level of collaboration the industry has not engaged in before, transcending boundaries and stimulating a growth in innovation.
 
view
download pdf
bullet
DATA MANAGEMENT
Q&A: Investigator Site Data

Joint Ventures


Through collaborative efforts such as the Shared Investigator Platform, biopharma partners are working to lessen administrative burdens for investigators and enhance the patient experience. Jackie Kent of Eli Lilly and TransCelerate talks to EPC.
 
view
download pdf
bullet
Risk Management
Pharmacovigilance

Progress Report


EPC offers a run-down of specific measures being implemented by the EMA to maximise the efficiency of the EudraVigilance safety reporting system for adverse events, following a significant decline in signals in 2014.
 
view
download pdf

Research and Development
Preclinical Development

Non-Clinics: Progression

Exploring the changing face of non-clinical development, Envigo's Lee Coney looks at the intricacies of investigating the safety and pharmacology of biologic drugs before they enter clinical trials, and the essential role of CRO players.
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

Digital Manufacturing is a top priority for Life Sciences according to Zenith survey

Zenith Technologies, a world leader in delivering GMP manufacturing software solutions to the life sciences industry, recently conducted an industry survey that suggests the digital manufacturing is a top priority.
More info >>

White Papers

Recommendations Sourcing Human Biospecimens

BioIVT

The foundations for protecting human research subjects come from the ethical principles surrounding the Belmont report : Respect for persons, beneficence, and justice. The use of human biospecimens in research supports these principles with legal and ethical regulations - the most important of which is permission.(1) This permission may come directly from the donor or granted by others with authorization to protect the interests of biospecimen donors.
More info >>

Industry Events

14th Annual Biomarkers Congress

21-22 February 2019, Manchester Central Convention Complex, UK

Oxford Global is proud to present for the 14th year our flagship Biomarkers Congress, taking place 21 22 February 2019 in Manchester, UK. An updated programme ensures you will benefit from talks on the latest strategies and technologies impacting growth in the biomarker industry.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement